Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hauel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of International Medical Research|June 8, 2001
Effects of telmisartan on renal excretory function in conscious dogsH Schierok, M Pairet, N Hauel, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2007
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosisW Wienen, J-M Stassen, H Priepke, et al.
British Journal of Pharmacology|September 1, 1993
Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277W Wienen, N Hauel, J C Van Meel, et al.
Arzneimittel-Forschung|February 1, 1993
Angiotensin II receptor antagonistsJ C van Meel, M Entzeroth, N Hauel, et al.
The EMBO Journal|December 18, 2001
A highly selective telomerase inhibitor limiting human cancer cell proliferationK Damm, U Hemmann, P Garin-Chesa, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of International Medical Research|June 8, 2001
Effects of telmisartan on renal excretory function in conscious dogsH Schierok, M Pairet, N Hauel, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2007
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosisW Wienen, J-M Stassen, H Priepke, et al.
British Journal of Pharmacology|September 1, 1993
Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277W Wienen, N Hauel, J C Van Meel, et al.
Arzneimittel-Forschung|February 1, 1993
Angiotensin II receptor antagonistsJ C van Meel, M Entzeroth, N Hauel, et al.
The EMBO Journal|December 18, 2001
A highly selective telomerase inhibitor limiting human cancer cell proliferationK Damm, U Hemmann, P Garin-Chesa, et al.
Pageof 1